Profile
Michael Dambach currently works at Reata Pharmaceuticals, Inc., as Director from 2023.
Michael Dambach active positions
| Companies | Position | Start |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Director/Board Member | 2023-09-25 |
Experiences
Positions held
Connections
26
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Stock Market
- Insiders
- Michael Dambach
